InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Freeman Mason, Directeur Exécutif du Développement Clinique. Officer active across 1 company, notably CinCor Pharma, Inc.. Cumulatively, 3 filings have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €35k. History available since 11 January 2022. The latest transaction was disclosed on 10 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Mason Freeman is the EVP Clinical Development at CinCor Pharma, Inc. In this role, he oversees clinical development programs and ensures that clinical trials are conducted in compliance with regulatory standards. His expertise is essential for the success of the company's research initiatives.